ReviewAlzheimer's research & therapy2014

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics.

William F Goure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.